213 related articles for article (PubMed ID: 25302177)
1. Cervical cancer: Can it be prevented?
Aggarwal P
World J Clin Oncol; 2014 Oct; 5(4):775-80. PubMed ID: 25302177
[TBL] [Abstract][Full Text] [Related]
2. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
[TBL] [Abstract][Full Text] [Related]
3. Current Status and Future Perspectives of Molecular Prevention Strategies for Cervical Cancers.
Krishnamurthy A; Ramshankar V
Indian J Surg Oncol; 2020 Dec; 11(4):752-761. PubMed ID: 33299288
[TBL] [Abstract][Full Text] [Related]
4. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.
Mapanga W; Girdler-Brown B; Feresu SA; Chipato T; Singh E
Syst Rev; 2018 Nov; 7(1):198. PubMed ID: 30447695
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].
Monsonego J
Presse Med; 2007 Apr; 36(4 Pt 2):640-66. PubMed ID: 17350792
[TBL] [Abstract][Full Text] [Related]
7. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India.
Sankaranarayanan R; Nene BM; Dinshaw K; Rajkumar R; Shastri S; Wesley R; Basu P; Sharma R; Thara S; Budukh A; Parkin DM
Salud Publica Mex; 2003; 45 Suppl 3():S399-407. PubMed ID: 14746033
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
[TBL] [Abstract][Full Text] [Related]
9. Cancer prevention: cervical cancer.
Ngoma M; Autier P
Ecancermedicalscience; 2019; 13():952. PubMed ID: 31552125
[TBL] [Abstract][Full Text] [Related]
10. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.
Brinkman JA; Caffrey AS; Muderspach LI; Roman LD; Kast WM
Eur J Gynaecol Oncol; 2005; 26(2):129-42. PubMed ID: 15857016
[TBL] [Abstract][Full Text] [Related]
11. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
12. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
13. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
14. Anal dysplasia screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
[TBL] [Abstract][Full Text] [Related]
15. A critical assessment of screening methods for cervical neoplasia.
Sankaranarayanan R; Gaffikin L; Jacob M; Sellors J; Robles S
Int J Gynaecol Obstet; 2005 May; 89 Suppl 2():S4-S12. PubMed ID: 15823266
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low- resource countries: example of India.
Saxena U; Sauvaget C; Sankaranarayanan R
Asian Pac J Cancer Prev; 2012; 13(4):1699-703. PubMed ID: 22799391
[TBL] [Abstract][Full Text] [Related]
17. Prospects for controlling cervical cancer at the turn of the century.
Franco EL; Duarte-Franco E; Ferenczy A
Salud Publica Mex; 2003; 45 Suppl 3():S367-75. PubMed ID: 14746030
[TBL] [Abstract][Full Text] [Related]
18. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
19. Role of VIA in cervical cancer screening in low-resource countries.
Nahar KN; Nessa A; Shamim S; Nasrin B; Hossain F; Begum N
Mymensingh Med J; 2011 Jul; 20(3):528-35. PubMed ID: 21804524
[TBL] [Abstract][Full Text] [Related]
20. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
